Found 37 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of ProQuad® rHA in Infants (V221-037) PHASE3 Primary objective: To describe the safety profile of a second dose of ProQu...
Show More Location
Multiple Locations
Learn More & Join Trial
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) PHASE3 The study is being conducted to demonstrate that V221 may be administered c...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine PHASE3 The purpose of this study is to evaluate the safety, tolerability, and immu...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children PHASE3 The purpose of this study is to assess the immunogenicity and safety of GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age PHASE2 The purpose of this observer blinded study is to provide information on vac...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) PHASE4 Hepatitis A vaccine will be given either alone or together with measles, mu...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age PHASE3 The purpose of this study is to support licensure of GSK Biologicals' MMR v...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers PHASE3 Safety immune response of Novartis MenACWY-CRM conjugate vaccine when given...
Show More Location
Site 85 - Birmingham Pediatric Associates, 806 St. Vincent's Drive
Learn More & Join Trial
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant EARLY_PHASE1 A prospective, multisite study to evaluate the Impact of Measles, Mumps, Ru...
Show More Location
Medical University of South Carolina, Pediatric Nephrology
Learn More & Join Trial